针注射增加了维生素B12对糖尿病神经病变的疗效:一个元分析和试验序列分析
Yunfeng Yu1,2, Tongyi Zhou2, Liu Li1
1School of Traditional Chinese Medicine, Hunan University of Chinese Medicine, Changsha, China.
European journal of clinical nutrition
|May 23, 2025
概括
与其他方法相比,维生素B12针注射显著改善了糖尿病神经病变患者的神经功能. 这种治疗增强了神经传导速度,而不会增加不良事件,这表明它.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 基于证据的医学 基于证据的医学
背景情况:
- 糖尿病神经病变 (DN) 是糖尿病的常见并发症,导致显著的发病率.
- 目前用于DN的治疗方法在有效性和安全性方面存在局限性.
- 维生素B12因其在神经健康中的作用而闻名,但DN的最佳管理途径需要研究.
研究的目的:
- 系统地评估维生素B12针注射与治疗糖尿病神经病变的其他施用途径的疗效和安全性.
- 为了比较对神经功能,血糖控制和不良事件的影响.
主要方法:
- 20项随机对照试验的元分析和试验顺序分析 (TSA) 涉及1688名参与者.
- 提取的数据包括临床有效性,神经传导速度 (运动和感觉),血糖水平和不良事件.
- 对包括的研究进行了偏差风险评估.
主要成果:
- 针注射显著提高了临床有效性 (RR 1.28) 和多个神经导电速度 (脚部和中部神经).
- 没有观察到对空腹血糖 (FBG) 或2小时食后血糖 (2h-PBG) 的显著影响.
- 针注射并没有显著增加不良事件的发生率 (RR 1.44). 除了FBG,2h-PBG和不良事件之外,TSA证实了大多数结果的确结果.
结论:
- 维生素B12针注射是改善糖尿病神经病变患者神经功能的一种优越的施用途径.
- 与其他维生素B12注射途径相比,这种方法显示出良好的疗效和安全性.
- 针注射可能是治疗糖尿病神经病变的最佳治疗策略.
更多相关视频
08:20Author Spotlight: Unveiling the Therapeutic Effects of FSN Treatment – Bridging Research and Clinical Applications in Neuropathic Pain
Published on: June 30, 2023
2.7K
05:56Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting
Published on: June 21, 2024
1.9K
相关概念视频
01:21Drug Accumulation During Multiple Dosing: Repetitive IV Injections
256
Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
256
01:24Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
233
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
233